The information on this page is archived and provided for reference purposes only. Please go to the SEER homepage to access current information.

Historical Landmark Studies in End Results

The contents of this section were published in 2003 as part of SEER's 30th Anniversary celebration.

End Results in cancer have been evaluated by clinicians, epidemiologists, and health service researchers in various ways, including patterns of care, quality of life, years of survival, and the chance of developing a second malignancy. The trends in cancer survival and mortality, along with incidence, cost/economics, and policy, provide critical benchmarks by which the cancer research enterprise in the United States can measure the progress made against this disease.

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.